ClassID:

93431

C07C311/17 - CPC Classification

Classification description:

Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups; Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms

Recent Application in this class:
#1
20240254077
2024-08-01

METHODS OF TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE INCLUDING COMPOUNDS USEFUL THEREIN

#2
20240174603
2024-05-30

MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME

#3
20220396551
2022-12-15

EBNA1 inhibitors and their method of use

#4
20220324807
2022-10-13

Aromatic sulfonamide derivatives

#5
20220002231
2022-01-06

PARG inhibitors and method of use thereof

#6
20200299226
2020-09-24

Mild and efficient preparation method for α-acyloxyenamide compounds and use thereof in synthesis of amide and polypeptide

#7
20200188407
2020-06-18

Compounds and methods for inducing chondrogenesis

#8
20200181078
2020-06-11

EBNA1 inhibitors and their method of use

#9
20190210957
2019-07-11

Mild and efficient preparation method for α-acyloxyenamide compounds and use thereof in synthesis of amide and polypeptide

#10
20190133976
2019-05-09

Metabolically robust analogs of CYP-eicosanoids for the treatment of cardiac disease

#11
20190119210
2019-04-25

Aromatic sulfonamide derivatives

#12
20190077749
2019-03-14

Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B

#13
20180230092
2018-08-16

NOVEL ANTIVIRAL AGENTS AGAINST HBV INFECTION

#14
20180161324
2018-06-14

SHIP1 modulators and methods related thereto

#15
20180086699
2018-03-29

EBNA1 inhibitors and their method of use

#16
20180065908
2018-03-08

Chain multiyne compound, preparation method and application thereof

#17
20170334842
2017-11-23

INHIBITORS OF THE MITF MOLECULAR PATHWAY

#18
20170320828
2017-11-09

Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof

#19
20170275317
2017-09-28

Complexes and methods for their preparation

#20
20170129851
2017-05-11

Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases

#21
20170022153
2017-01-26

FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE

#22
20160311804
2016-10-27

Process for preparing 1,3-dihydroimidazole-2-thione derivatives

#23
20160289185
2016-10-06

EBNA1 inhibitors and their method of use

#24
20160257671
2016-09-08

SHIP1 modulators and methods related thereto

#25
20160130222
2016-05-12

Inhibitors of the MITF molecular pathway

#26
20160107996
2016-04-21

Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof

#27
20160045514
2016-02-18

Compounds and methods for inducing chondrogenesis

#28
20160031898
2016-02-04

Irreversible covalent inhibitors of the GTPase K-Ras G12C

#29
20160024004
2016-01-28

Antiviral agents against HBV infection

#30
20160002155
2016-01-07

Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B

#31
20150368433
2015-12-24

Photosensitive gas generating agent and photocurable composition

#32
20150315178
2015-11-05

Plasminogen activator inhibitor-1 inhibitors and methods of use thereof

#33
20150252003
2015-09-10

Use of a Compound for Inducing Differentiation of Mesenchymal Stem Cells into Cartilage Cells

#34
20150239831
2015-08-27

INHIBITORS OF CENTRAL NERVOUS SYSTEM VASOACTIVE INHIBITORY PEPTIDE RECEPTOR 2

#35
20150239829
2015-08-27

Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases

#36
20150197509
2015-07-16

Substituted sulfonamide compounds

#37
20140329860
2014-11-06

2-substituted--quinone derivatives for treatment of oxidative stress diseases

#38
20140271955
2014-09-18

Compounds and methods for inducing chondrogenesis

#39
20140221668
2014-08-07

Process for preparing 1, 3-Dihydroimidazole-2-Thione Derivatives

#40
20140121211
2014-05-01

Thiol mediated/activated prodrugs of sulfur dioxide (SO) having anti-bacterial activity

#41
20140094466
2014-04-03

SSH-2 (slingshot-2) inhibitors and methods for making and using them

#42
20140031331
2014-01-30

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

#43
20130338364
2013-12-19

Iodoarene derivative, method for manufacturing optically active spirolactone compound by using the same, and method for manufacturing optically active cycloadduct

#44
20130253053
2013-09-26

Method of treating skin with microRNA modulators

#45
20130236969
2013-09-12

Use of compounds for inducing differentiation of mesenchymal stem cells to chondrocytes

#46
20130225588
2013-08-29

Substituted naphthylacetic acids

#47
20130184279
2013-07-18

N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases

#48
20130184238
2013-07-18

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

#49
20130183252
2013-07-18

COMPOUNDS THAT INHIBIT (BLOCK) BITTER TASTE IN COMPOSITION AND METHODS OF MAKING SAME

#50
20130102609
2013-04-25

Biaryl oxyacetic acid compounds

#51
20130090385
2013-04-11

NOVEL SPECIFIC CASPASE-10 INHIBITORS

#52
20130012536
2013-01-10

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

#53
20120329877
2012-12-27

Cycloalkyl-dione derivatives and methods of their use

#54
20120322761
2012-12-20

Heterocyclic CETP inhibitors

#55
20120270902
2012-10-25

N-substituted benzene sulfonamides

#56
20120165373
2012-06-28

Method of treating skin with microRNA modulators

#57
20120061325
2012-03-15

Chelating compounds and immobilized tethered chelators

#58
20120035179
2012-02-09

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

#59
20110207937
2011-08-25

Compounds that inhibit (block) bitter taste in composition and methods of making same

#60
20110168636
2011-07-14

Removing aluminum from solution using chelating compounds and immobilized tethered chelators

#61
20110136877
2011-06-09

2-PHENYL PHENOXYACETIC ACIDS USEFUL FOR TREATING INFLAMMATORY DISORDERS

#62
20110130453
2011-06-02

Aminoalkylphenyl antagonists of prostaglandin D2 receptors

#63
20110124679
2011-05-26

2-substituted--quinone derivatives for treatment of oxidative stress diseases

#64
20110098253
2011-04-28

Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use

#65
20110071125
2011-03-24

SUBSTITUTED PHENYLAMINO-BENZENE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH MITOGEN EXTRACELLULAR KINASE ACTIVITY

#66
20110039819
2011-02-17

SUBSTITUTED PHENOXYBENZAMIDES

#67
20100273739
2010-10-28

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

#68
20100267669
2010-10-21

Heterocyclic CETP inhibitors

#69
20100222454
2010-09-02

DEGRADATION ACCELERATOR FOR POLYMERS AND POLYMER ARTICLE COMPRISING IT

#70
20100168112
2010-07-01

2-Substituted and 4-substituted aryl nitrone compounds

#71
20100137291
2010-06-03

Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use

#72
20100125090
2010-05-20

Modulators of ATP-Binding Cassette Transporters

#73
20100125076
2010-05-20

Substituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use

#74
20100120725
2010-05-13

Substituted Phenylsulfonamide Inhibitors of Beta Amyloid Production

#75
20100093708
2010-04-15

Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use

#76
20100093671
2010-04-15

Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use

#77
20100048950
2010-02-25

Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof

#78
20100041717
2010-02-18

N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases

#79
20090274632
2009-11-05

Compounds that inhibit (block) bitter taste in composition and use thereof

#80
20090261043
2009-10-22

Chelating compounds and immobilized tethered chelators

#81
20090253669
2009-10-08

Substituted Sulfonamide Compounds

#82
20090221711
2009-09-03

TRIFLUOROMETHYL-CONTAINING PHENYLSULFONAMIDE BETA AMYLOID INHIBITORS

#83
20090143466
2009-06-04

Isolation of atraric acid, synthesis of atraric acid derivatives, and use of atraric acid and the derivatives thereof for the treatment of benign prostatic hyperplasia, prostate carcinoma and spinobulbar muscular atrophy

#84
20090093485
2009-04-09

Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases

#85
20090082591
2009-03-26

METHODS FOR PREPARING SULFONAMIDE COMPOUNDS

#86
20090082328
2009-03-26

Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity

#87
20090023930
2009-01-22

PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF HETEROCYCLIC SULFONAMIDE COMPOUNDS

#88
20090023801
2009-01-22

INHIBITORS OF BETA AMYLOID PRODUCTION

#89
20080306084
2008-12-11

Substituted amide compounds

#90
20080287477
2008-11-20

Novel Compounds as Modulators of Ppar

#91
20080182906
2008-07-31

Specific caspase-10 inhibitors

#92
20080119555
2008-05-22

Aryl alkyl sulfonamides as therapeutic agents for the treatment of bone conditions

#93
20080090829
2008-04-17

SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS

#94
20070299117
2007-12-27

Hydroxypropylaimines

#95
20070249723
2007-10-25

Methods for preparing sulfonamide compounds

#96
20070249722
2007-10-25

Trifluoromethyl-containing phenylsulfonamide beta amyloid inhibitors

#97
20070213316
2007-09-13

N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives

#98
20070197800
2007-08-23

Selective N-sulfonylation of 2-amino fluoro- and trifluoroalkyl substituted alcohols

#99
20070149577
2007-06-28

Compounds with medicinal effects due to interaction with the glucocorticoid receptor

#100
20070135631
2007-06-14

Heterocyclic CETP inhibitors

#101
20070105914
2007-05-10

Substituted sulfonamides

#102
20070088027
2007-04-19

Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient

#103
20070082907
2007-04-12

Peroxisome proliferator activated receptor modulators

#104
20070071782
2007-03-29

2-Cyanobenzenesulfonamides for combating animal pests

#105
20070037778
2007-02-15

Substituted phenylsulfonamide inhibitors of beta amyloid production

#106
20060229363
2006-10-12

Substituted Heteroaryl- and Phenylsulfamoyl Compounds

#107
20060217433
2006-09-28

Sulfonamide derivatives as PPAR modulators

#108
20060166990
2006-07-27

Aminobenzophenone compounds

#109
20060110343
2006-05-25

Cosmetic or dermopharmaceutical compositions comprising tyramine derivatives, method for preparing same, and use thereof

#110
20060052396
2006-03-09

Arylamines for the treatment of conditions associated with gsk-3

#111
20050288340
2005-12-29

Substituted heteroaryl- and phenylsulfamoyl compounds

#112
20050272774
2005-12-08

Substituted cyclohexane derivatives

#113
20050245573
2005-11-03

N-substituted benzene sulfonamides

#114
20050222243
2005-10-06

Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use

#115
20050182060
2005-08-18

2-Substituted and 4-substituted aryl nitrone compounds

#116
20050153958
2005-07-14

Substituted aryl ketones

#117
20050148648
2005-07-07

Modulators of ATP-binding cassette transporters

#118
20050143583
2005-06-30

Processes for the preparation of substituted isoxazoles and 2-isoxazolines

#119
20050113450
2005-05-26

Antibacterial agents

#120
20050038259
2005-02-17

Hydroxyeicosenoic acid anaglogs

#121
20050020680
2005-01-27

Hydroxyfattysulfonic acid analogs

#122
20050014840
2005-01-20

Thiol sulfonamide metalloprotease inhibitors